| Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies JM Rocha, JAS Reis, JC Bouso, JEC Hallak, RG Dos Santos European Archives of Psychiatry and Clinical Neuroscience 273 (7), 1527-1542, 2023 | 8 | 2023 |
| Guidelines for Establishing Safety in Ayahuasca and Ibogaine Administration in Clinical Settings JM Rocha, JAS Reis, GN Rossi, JC Bouso, JEC Hallak, RG dos Santos Psychoactives 2 (4), 373-386, 2023 | 1 | 2023 |
| Subjective effects of a single dose of ayahuasca among college students with harmful alcohol use: qualitative analysis of participant accounts AB Vicentini, LS Rodrigues, GN Rossi, JM Rocha, LTL Guerra, JAS Reis, ... Psychoactives 2 (4), 346-358, 2023 | 1 | 2023 |
| Interventions for deficits in recognition of emotions in facial expressions in major depressive disorder: An updated systematic review of clinical trials JAS Reis, GN Rossi, FL Osorio, JC Bouso, JEC Hallak, RG Dos Santos Neuroscience & Biobehavioral Reviews 153, 105367, 2023 | 1 | 2023 |
| Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use: A Single-blind, Feasibility, Proof-of-Concept Trial LS Rodrigues, JAS Reis, GN Rossi, LTL Guerra, RM Maekawa, ... Journal of Clinical Psychopharmacology 44 (4), 402-406, 2024 | | 2024 |
| Current Evidence of Cannabidiol's Potential as an Anxiolytic Agent GN Rossi, JAS Reis, JEC Hallak, RG Santos Psychiatric Annals 53 (6), 242-246, 2023 | | 2023 |
